Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling
Open Access
- 29 June 2015
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 138 (3), 668-675
- https://doi.org/10.1016/j.ygyno.2015.06.036
Abstract
No abstract availableKeywords
Funding Information
- NIH/NCI (1K23CA143154-01A1)
- Steelman fund
This publication has 40 references indexed in Scilit:
- Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cellsJournal of Hematology & Oncology, 2015
- Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic mediumCell Death & Disease, 2014
- D-Glucose-Induced Cytotoxic, Genotoxic, and Apoptotic Effects on Human Breast Adenocarcinoma (MCF-7) CellsJournal of Cancer Science & Therapy, 2014
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast CancersPathology and Oncology Research, 2012
- Central role of lactic acidosis in cancer cell resistance to glucose deprivation‐induced cell deathThe Journal of Pathology, 2011
- Glucose Metabolism Disorders and the Risk of CancerArchivum Immunologiae et Therapiae Experimentalis, 2011
- Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorshipGynecologic Oncology, 2009
- Obesity related hyperinsulinaemia and hyperglycaemia and cancer developmentArchives of Physiology and Biochemistry, 2009
- Molecular and Pathologic Aspects of Endometrial CarcinogenesisJournal of Clinical Oncology, 2006